Search Site

Mitchell S.V. Elkind, MD, MS, MPhil

  • Professor of Neurology and Epidemiology (in the Gertrude H. Sergievsky Center)
Mitchell S.V. Elkind, MD, MS, MPhil

Dr. Mitchell Elkind is a Professor of Neurology at Columbia University College of Physicians and Surgeons in New York City and an Attending Neurologist on the Stroke Service at the NewYork-Presbyterian Hospital. He is also the past Director of the Neurology Residency Training Program. Dr. Elkind received his undergraduate degree from Harvard College and a master's degree in the History and Philosophy of Science from Cambridge University in England. After receiving his medical degree in 1992 from Harvard Medical School, he trained in internal medicine at Brigham and Women's Hospital in Boston, and in neurology at the Massachusetts General Hospital, where he was Chief Resident 1995-6. He completed his master's degree in epidemiology at the Columbia University School of Public Health in 1998, as well as fellowship training in cerebrovascular diseases working with Drs. Ralph Sacco and J. P. Mohr.

Dr. Elkind is a co-investigator in the Northern Manhattan Stroke Study, and is the recipient of grants from the American Heart Association (AHA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH) to study the relationship between infection, inflammation and stroke. He has participated in several clinical trials of acute and preventive stroke therapy, and has lectured extensively on cerebrovascular disease. His clinical work is directed toward the care of patients with stroke.

He is the author of a medical student board review text on neurology. He is a member of the American Heart Association, National Stroke Association, and American Academy of Neurology.

Research focuses on different inflammatory markers and infections, such as C. pneumoniae and periodontal disease, as potential causes of atherosclerosis and ischemic stroke; se of high-resolution duplex doppler ultrasonography as a measure of stroke risk; amd clinical trials of neuroprotectants and surgical hemicraniectomy for acute stroke, and antiplatelet and of other therapies for stroke prevention.

Departmental Appointments

  • Department of Epidemiology
  • Department of Neurology
    Division of Stroke and Cerebrovascular Disease

Education & Training

  • Harvard Medical School
  • Internship: Brigham & Women's Hospital - Harvard
  • Residency: Massachusetts General Hospital
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Centers/Institutes/Programs

  • Gertrude H. Sergievsky Center

Research Interests

  • Relationship between infection, inflammation and stroke

NIH Grants

  • CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

    Jul 1 2016 - May 31 2021

    IMPACT OF PTSD ON CARDIOVASCULAR RISK IN SURVIVORS OF STROKE AND TRANSIENT ISCHEMIC ATTACK (Federal Gov)

    Jun 20 2016 - Mar 31 2020

    NEUROEPIDEMIOLOGY TRAINING PROGRAM (Federal Gov)

    Jul 1 2014 - Jun 30 2019

    COLUMBIA GENIE (GENOMIC INTEGRATION WITH EHR) (Federal Gov)

    Sep 1 2015 - May 31 2019

    PREVALENCE AND PREDICTORS OF ASYMPTOMATIC ATRIAL FIBRILLATION IN THE COMMUNITY (Federal Gov)

    Apr 1 2014 - Jan 31 2019

    BIOGEN IDEC SCIENTIFIC LEADER ACTIVITIES ON PROTOCOL 101SK201. A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF IV NATALIZUMAB (BG00002) (P&S Industry Clinical Trial)

    Aug 26 2013 - Aug 26 2018

    THE TRAJECTORY OF FUNCTIONAL STATUS AND QUALITY OF LIFE BEFORE AND AFTER STROKE (Federal Gov)

    Apr 1 2013 - Mar 31 2018

    TRIAGE AND OUTPATIENT EVALUATION OF PATIENTS WITH TIA AND MINOR STROKE THE RAPID ACCESS VASCULAR EVALUATION-NEUROLOGY (RAVEN) APPROACH (NY State Gov)

    Dec 31 2015 - Dec 30 2017

    NEW YORK COLUMBIA COLLABORATIVE SPOTRIAS (Federal Gov)

    Aug 1 2010 - Jul 31 2016

    COMPARATIVE EFFECTIVENESS ANALYSIS OF TREAT-TO-TARGET AND RISK-BASED BLOOD PRESSURE CONTROL GUIDELINES (Federal Gov)

    Aug 19 2011 - Jun 30 2016

    PHYSICAL ACTIVITY PATTERNS VIA NEW DIMENSION-INFORMATIVE CLUSTER MODELS (CHEUNG/ELKIND) (Federal Gov)

    Aug 17 2012 - Apr 30 2016

    FGF-23 AND PHOSPHORUS IN STROKE, SUBCLINICAL VASCULAR DAMAGE, AND COGNITION (Federal Gov)

    Mar 16 2012 - Feb 28 2016

    STROKE INCIDENCE AND RISK FACTORS IN A TRI-ETHNIC REGION (Federal Gov)

    Sep 30 2015 - Dec 31 2015

    MINORITIES WITH ICH (Federal Gov)

    Jul 1 2010 - Jul 31 2015

    MINORITIES WITH ICH (Federal Gov)

    Jul 1 2010 - Jun 30 2015

    STROKE INCIDENCE AND RISK FACTORS IN A TRI-ETHNIC REGION (Federal Gov)

    Apr 1 2008 - Mar 31 2015

    MECHANISMS OF EARLY RECURRENCE IN INTRACRANIAL ATHEROSCLEROTIC DISEASE (Federal Gov)

    Mar 1 2014 - Feb 28 2015

    VASCULAR EFFECTS OF INFECTION IN PEDIATRIC STROKE (Federal Gov)

    Aug 5 2009 - Jul 31 2014

    MODIFIABLE RISK FACTORS IN STROKE INCIDENCE AND MORTALITY AMONG WOMEN (Federal Gov)

    Jul 1 2011 - Jun 30 2014

    THE VERTEBROBASILAR FLOW EVALUATION AND RISK OF TRANSIENT ISCHEMIC ATTACK & STROKE (VERITAS) STUDY (Federal Gov)

    Jul 1 2009 - Jun 30 2014

    VASCULAR EFFECTS OF INFECTION IN PEDIATRIC STROKE (Federal Gov)

    Aug 5 2009 - Jul 31 2013

    THE ROLE OF COPETIN, MIDREGIONAL NATRIURETIC PEPTIDE AND PROCALCITONIN AS MARKERS OF ISCHEMIC STROKE RISK IN THE NORTHERN MANHATTAN STUDY (Private)

    Jan 1 2012 - May 31 2013

    STENTING VS AGGRESSIVE MEDICAL MANAGEMENT FOR PREVENTING RECURRENT EVENTS IN INTRACRANIAL STENOSIS (SAMMPRIS) (Federal Gov)

    May 1 2008 - Apr 30 2013

    STROKE INCIDENCE AND RISK FACTORS IN A TRI-ETHNIC REGION (Federal Gov)

    Apr 1 2008 - Mar 31 2013

    USE OF A MENTORED PEER REVIEW PROGRAM TO ENHANCE NEUROLOGY R ESIDENT EDUCATION ON THE BASIC CONCEPTS OF BIOSTATISTICS, RE (Private)

    Jan 1 2012 - Dec 31 2012

    LEVELS OF INFLAMMATORY MARKERS IN THE TREATMENT OF STROKE (LIMITS) (P&S Industry Clinical Trial)

    May 18 2004 - Aug 17 2012

    SECONDARY PREVENTION OF SMALL SUBCORTICAL STOKES (Federal Gov)

    Dec 1 2009 - Jul 31 2012

    VASCULAR EFFECTS OF INFECTION IN PEDIATRIC STROKE (Federal Gov)

    Aug 5 2009 - Jul 31 2012

    VIPS: VASCULAR EFFECTS OF INFECTION IN PEDIATRICS STROKE (Federal Gov)

    Aug 5 2009 - Jul 31 2012

    LP-PLA2 AND RISK OF STROKE IN A PROSPECTIVE COHORT STUDY IN A MULTI-ETHNIC POPULATION (Private)

    Jan 13 2010 - Jan 12 2012

    SECONDARY PREVENTION OF SMALL SUB-CORTICAL STROKES - (SPS3) (Federal Gov)

    Feb 8 2008 - Jun 30 2011

    NMT MEDICAL--G980031 (P&S Industry Clinical Trial)

    Aug 9 2007 - Jun 30 2011

    LEVELS OF INFLAMMATORY MARKERS IN TREATMENT OF STROKE (Federal Gov)

    May 25 2005 - Apr 30 2011

    INFLAMMATORY AND INFECTIOUS BURDEN AND RISK OF STROKE (Federal Gov)

    Mar 1 2004 - Feb 28 2011

    INFLAMMATION, LEUKOCYTE ACTIVATION, AND STROKE RISK (Private)

    Jul 1 2003 - Jun 30 2007